Immunogenicity Testing: Challenges and Strategies

Hosted by The Scientist, this live webinar brings together a panel of experts who will discuss the mechanisms underlying immune and allergenic responses and highlight some of the current and emerging bioanalytical techniques used for their assessment.

By | February 19, 2013

FREE Webinar
Wednesday March 13, 2013
2:30 p.m. - 4:00 p.m. Eastern Time
View the Video Now!

A drug-induced immune response can significantly alter the safety and efficacy of biotherapeutic drugs. Hence, early testing and prediction of potential immunogenicity and allergenicity caused by these drugs is essential, but can be quite challenging. Hosted by The Scientist, this live webinar brings together a panel of experts who will discuss the mechanisms underlying immune and allergenic responses and highlight some of the current and emerging bioanalytical techniques used for their assessment. The panelists will highlight the advantages and disadvantages of various assays that use ligand binding, electrochemical detection, surface plasmon resonance, and other methods for detection, and discuss ways to tackle inherent interferences and shortcomings particular to the various assays. They will also discuss some of the current Clinical Laboratory Standards Institute (CLSI) guidelines for assay design and validation for assessing the allergenicity of biotherapeutics.

View the video now!

Panelists and topics to be covered:

Immunogenicity Evaluation of Biotherapeutics: Bioanalytical Methods and Strategies
Dr. Boris Gorovits is a director in the Pharmacokinetics Pharmacodynamics and Metabolism department of Pfizer Inc. Boris earned his Ph.D. in Enzymology at the Moscow State University and then completed postdoctoral studies in Protein Biophysics at the Medical Center, University of Texas at San Antonio. Boris later joined Wyeth Research (now Pfizer) where he currently leads a Bioanalytical laboratory responsible for support of the R&D of protein based pharmaceuticals. His research is focused on developing and utilization of PK assays as well as the assays designed to evaluate development of immune responses to biotherapeutic compounds.

Developing Fit for Purpose Immunogenicity Assays
Dr. Maureen Deehan is head of pharmacology, in the Experimental Science & Translational Medicine Department at NovImmune SA, in Geneva, Switzerland. Novimmune SA is a biotechnology company with expertise in the development of fully human monoclonal antibodies. Her group supports preclinical and clinical programs by developing assays for target validation, in vitro pharmacology, pharmacokinetics, immunogenicity, safety, and biomarkers.

Design and Validation of Immunoassays for Assessment of Allergenicity of Biotherapeutics
Dr. Robert Hamilton is a professor of medicine and pathology and director of the Dermatology, Allergy and Clinical Immunology Reference Laboratory at the Johns Hopkins University School of Medicine. He teaches, performs research and directs a federally licensed clinical immunology laboratory that performs diagnostic allergy testing. His current research focuses on the assessment of immunogenicity and allergenicity of a selection of new drugs.



Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo


Avatar of: Iris Lopez

Iris Lopez

Posts: 1

March 10, 2013

Muy interesante su ponencia y les felicito.Mi hija tiene un problema con su estomago. Fue diagnosticada con Gastritis atrofica. Ha perdido mucho peso. Ella no tiene la mucosa del estomago. No se si  esto fue debido a sus habitos alimentarios o su condicion de Esclerosis tuberosa. Seria posible crear implantes de las celulas de la mucosa y volver hacer crecer tejido o un transplante completo del estomago? Me interesaria saber. No la quiero ver con dolores y sin querer comer por miedo al dolor.No se si soy ignorante en relacion a este tema. Deseo la ayuden

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  3. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  4. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

Life Technologies